99.25%
Lot
HAL-202608-967
Purity
99.33%
- Form
- Lyophilised powder
- Storage
- −20 °C, desiccated
- Stability
- 24 months
- CAS
- 121062-08-6
- Formula
- C50H69N15O9
- Molecular weight
- 1024.18 g/mol
- Solubility
- Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
Melanotan II
Cyclic α-MSH analogue
£37
Vial massMELANOTANII-10-HAL
1
46 vials in stock · dispatched within 24 h
A lactam-bridged cyclic heptapeptide analogue of α-MSH. The constrained ring system makes it a standard reference for melanocortin receptor binding panels.
MC1R/MC4R bindingCyclisation chemistry
Supplied for laboratory research use only. Not for human or veterinary use, consumption, or clinical application.
Analysis
Certificate of analysis
RP-HPLC chromatogramJanoshik Analytical
Retention time (min)λ 214 nm
Purity99.33%
Specification ≥ 98.0%
- Lot
- HAL-202608-967
- Released
- 2026-08-03
- Mass expected
- 1024.18 Da
- Mass found
- 1024.03 Da
- Water (KF)
- 3.58%
- Endotoxin
- 0.154 EU/mg
- Appearance
- White lyophilisate
Primary structure
8 residues
Hover a residue for detail
- Formula
- C50H69N15O9
- Molecular weight
- 1024.18 g/mol
Interactive
Reconstitution
Vial mass
mL
mcg
Syringe
- Draw to
- 5.0 units
- Volume
- 0.050 mL
- Concentration
- 5.00 mg/mL
- Draws per vial
- 40
Arithmetic for Melanotan II at the values you entered. Not a protocol and not a dose recommendation. Research use only.
Handling
- On arrival
- Transfer to −20 °C within two hours. Vials ship on phase-change packs rated for 72 hours.
- Reconstitution
- Bacteriostatic water or 0.9% NaCl, ≥2 mg/mL
- After reconstitution
- 2–8 °C, use within 28 days. Aliquot to avoid freeze-thaw cycling.
- Shelf life
- 24 months lyophilised, desiccated and protected from light.